Brief: Grifols Launches Fibrinogen Concentrate For Acute Bleeding Episodes In The U.S.
15/06/2026 13:05
BRIEF-Grifols Launches Fibrinogen Concentrate For Acute Bleeding Episodes In The U.S. June 15 (Reuters) - Grifols SA GRLS.MC:
LAUNCHES NEW FIBRINOGEN CONCENTRATE FESILTY (FIBRINOGEN, HUMAN-CHMT) IN THE U.S.
FESILTY TO BE USED FOR ACUTE BLEEDING EPISODES IN PEDIATRIC AND ADULT PATIENTS WITH CONGENITAL FIBRINOGEN DEFICIENCY
Further company coverage: GRLS.MC
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 567 69 66 00;))
Recent news on Grifols SA
See all newsSpanish stocks - Factors to watch on June 24
Brief: Grifols Approves Reduction Of Up To 10% Of Its Share Capital
Brief: Grifols Launches Fibrinogen Concentrate For Acute Bleeding Episodes In The U.S.
Brief: Grifols' Egypt Unit Adds €180 Mln Of Additional Investment In Project
Spanish stocks - Factors to watch on June 12